Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review.

Author: LeffJared A, McCollisterKathryn E, MurphySean M, OnuohaErica N, PolskyDaniel, SchackmanBruce R

Paper Details 
Original Abstract of the Article :
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration-approved medications for treatment of opioid use disorder: methadone, buprenorphine, and injectable extended-release naltrexone (XR-NTX). The comparative effectiveness ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/34243831

データ提供:米国国立医学図書館(NLM)

Evaluating Medications for Opioid Use Disorder: A Systematic Review

The opioid crisis is a global concern, straining healthcare resources. This systematic review dives deep into the economic impact of using medications like methadone, buprenorphine, and injectable extended-release naltrexone (XR-NTX) to treat opioid use disorder. The authors meticulously analyzed existing research to understand the effectiveness and cost variations among these medications, aiming to guide stakeholders towards making informed decisions about resource allocation.

Understanding the Economic Impact of Medications

This review provides valuable insights into the costs associated with different opioid use disorder treatments. By carefully evaluating the effectiveness and cost-effectiveness of each medication, stakeholders can make informed decisions about which treatment options are most appropriate for different patients and situations.

Finding the Right Path in a Desert of Opioid Crisis

Just like navigating a vast desert, tackling the opioid crisis requires careful planning and resource management. Understanding the economic implications of treatment options can help us find the most efficient and effective paths towards recovery for those suffering from opioid use disorder.

Dr.Camel's Conclusion

This research provides a valuable roadmap for navigating the complex landscape of opioid use disorder treatment. By understanding the costs and benefits of different medications, we can make more informed decisions and optimize resource allocation, ultimately leading to better outcomes for patients.

Date :
  1. Date Completed 2021-12-24
  2. Date Revised 2022-07-16
Further Info :

Pubmed ID

34243831

DOI: Digital Object Identifier

NIHMS1749437

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.